Cetera Advisors’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-26,256
Closed -$557K 1658
2022
Q4
$557K Buy
26,256
+2,222
+9% +$46.1K 0.01% 922
2022
Q3
$489K Buy
+24,034
New +$479K 0.01% 787

Other funds holding BTAL

Cetera Advisors's BTAL Position: Q1 2023 in Review

Cetera Advisors sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q1 2023, closing a stake of 26,256 shares — an estimated $557K sold.

Cetera Advisors first reported a position in BTAL in Q3 2022 and held it in 2 quarters. The position peaked at $557K in Q4 2022. 89 funds tracked by Wall St. Rank hold BTAL as of Q1 2023.

  • Cetera Advisors reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q1 2023 after selling out during the quarter.
  • Cetera Advisors sold 26,256 AGF US Market Neutral Anti-Beta Fund shares in Q1 2023, an estimated $557K.
  • Cetera Advisors first reported a position in AGF US Market Neutral Anti-Beta Fund in Q3 2022 and held it in 2 quarters.
  • Cetera Advisors's AGF US Market Neutral Anti-Beta Fund position peaked at $557K in Q4 2022.
  • 89 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q1 2023.

Based on Cetera Advisors's 13F filing for Q1 2023, filed 15 May 2023.